Citius Oncology, Inc.
CTOR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851484
No open-market purchases or sales by Citius Oncology, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $9.20M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Citius Oncology, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 6 | 7 | +1 |
| Shares | 105.0K | 227.5K | +122.5K (+116.6%) |
| Value | $97.7K | $989.6K | +$891.9K (+913.3%) |
New holders (2)
Institutions that held Citius Oncology, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 106,970 | $465.3K | 0.00% |
| Arkadios Wealth Advisors | 11,666 | $50.7K | 0.00% |
Sold out (1)
Institutions that held Citius Oncology, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Yakira Capital Management, Inc. | 11,999 | $11.2K |